Image source: The Motley Fool.
Synopsys Inc (NASDAQ:SNPS)Q12019 Earnings Conference CallFeb. 20, 2019, 5:00 p.m. ET
Prepared Remarks Questions and Answers Call Participants
Ladies and gentlemen thank you for standing by and welcome to the Synopsys Earnings Conference Call for the First Quarter Fiscal Year 2019. At this time, all participants are in a listen-only mode and then later, we will conduct a question-and-answer session and instructions will be given at that time. (Operator Instructions)
Today’s call will last one hour. Five minutes prior to the end of the call, we will announce the amount of time remaining in the conference. As a reminder, today’s call is being recorded.
At this time, I would like to turn the conference over to Lisa Ewbank, Vice President of Investor Relations. Please go ahead.
Top Undervalued Stocks To Watch Right Now: Layne Christensen Company(LAYN)
Layne Christensen Company (“Layne”, “our”, “we” or “us”) is a leading global water management and services company, with more than 130 years of industry experience, providing responsible, integrated solutions to address the world’s toughest water, mineral and energy challenges. Our customers include government agencies, investor-owned utilities, industrial companies, global mining companies, consulting engineering firms, heavy civil construction contractors, oil and gas companies, power companies and agribusiness.
We operate on a geographically dispersed basis, with approximately 78 sales and operations offices located throughout North America, South America, and through our affiliates in Latin America countries. Layne maintains executive offices at 1800 Hughes Landing Boulevard, Suite 800, The Woodlands, Texas 77380. Advisors’ Opinion:
- [By Stephan Byrd]
Barclays PLC increased its holdings in shares of Layne Christensen (NASDAQ:LAYN) by 1,886.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 56,851 shares of the construction company’s stock after acquiring an additional 53,989 shares during the period. Barclays PLC’s holdings in Layne Christensen were worth $848,000 at the end of the most recent reporting period.
- [By Ethan Ryder]
Here are some of the news articles that may have impacted Accern’s rankings:
Get Layne Christensen alerts:
Critical Survey: Layne Christensen (LAYN) and Real Goods Solar (RGSE) (americanbankingnews.com) Glass Lewis joins ISS in supporting Layne Christensen buyout (seekingalpha.com) Glass Lewis Joins ISS in Recommending that Layne Christensen Stockholders Vote for the Proposed Merger with Granite (prnewswire.com) Net income boost as investors vote on Layne closure (globalwaterintel.com) Edited Transcript of LAYN earnings conference call or presentation 6-Jun-18 1:00pm GMT (finance.yahoo.com)
LAYN stock traded down $0.17 during trading hours on Tuesday, hitting $15.58. The company’s stock had a trading volume of 16,668 shares, compared to its average volume of 247,366. The company has a quick ratio of 0.85, a current ratio of 0.99 and a debt-to-equity ratio of 1.67. The company has a market capitalization of $318.08 million, a price-to-earnings ratio of -21.64 and a beta of 0.50. Layne Christensen has a 12 month low of $8.19 and a 12 month high of $16.96.
- [By Logan Wallace]
Headlines about Layne Christensen (NASDAQ:LAYN) have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern ranks the sentiment of media coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Layne Christensen earned a news sentiment score of 0.15 on Accern’s scale. Accern also gave media coverage about the construction company an impact score of 45.8722865003839 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.
Top Undervalued Stocks To Watch Right Now: Moelis & Company(MC)
Moelis & Company is a leading global independent investment bank that provides innovative strategic and financial advice to a diverse client base, including corporations, governments and financial sponsors. We assist our clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all major industry sectors. Our team of experienced professionals advises clients on their most critical decisions, including mergers and acquisitions (“M&A”), recapitalizations and restructurings and other corporate finance matters.
Moelis & Company was founded in 2007 by veteran investment bankers to create a global independent investment bank that offers multi-disciplinary solutions and exceptional transaction execution combined with the highest standard of confidentiality and discretion. Advisors’ Opinion:
- [By Motley Fool Transcribers]
Moelis & Company (NYSE:MC)Q42018 Earnings Conference CallFeb. 06, 2019, 5:00 p.m. ET
Prepared Remarks Questions and Answers Call Participants
- [By Logan Wallace]
Moelis & Co (NYSE:MC) has been given an average recommendation of “Buy” by the seven ratings firms that are currently covering the firm, Marketbeat reports. Three equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $62.17.
- [By Max Byerly]
MAN Grp PLC/ADR (NYSE: MC) and Moelis & Co (NYSE:MC) are both mid-cap finance companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, risk, earnings, profitability and institutional ownership.
Top Undervalued Stocks To Watch Right Now: icad inc.(ICAD)
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the early identification and treatment of cancer in the United States and internationally. It operates through two segments, Cancer Detection and Cancer Therapy. The company provides electronic brachytherapy (eBX) products, including Axxent eBx systems for the treatment of early stage breast cancer, endometrial cancer, and skin cancer, as well as for the treatment of other cancers or conditions where radiation therapy is indicated comprising intraoperative radiation therapy. It also offers digital mammography computer-aided detection (CAD) products, such as advanced image analysis and workflow solutions in breast imaging, which include SecondLook digital CAD systems that detects and identifies suspicious masses and micro-calcifications; and PowerLook Advanced Mammography Platform, a computer server residing on a customers network that receives patient studies from the imaging modality, performs CAD analysis, and sends the CAD results to picture archiving and communication system and/or review workstations. In addition, the companys digital mammography CAD products comprise magnetic resonance imaging applications, a tool to detect breast and prostate cancer; breast tomosynthesis systems; and advanced image analysis and workflow solutions in computed tomography (CT) colonography, including VeraLook that supports the detection of colonic polyps in conjunction with CT colonography. It serves hospitals, ambulatory care centers and free standing radiation oncology facilities, and other office-based uses. The company sells its products through sales organizations, as well as through various original equipment manufacturer partners, distributors, and resellers. It has a strategic partnership agreement with Invivo Corp. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was founded in 1984 and is headquartered in Nashua, New Hampshire.
- [By Max Byerly]
iCAD (NASDAQ:ICAD) announced its earnings results on Tuesday. The technology company reported ($0.06) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.12) by $0.06, Bloomberg Earnings reports. iCAD had a negative net margin of 61.83% and a negative return on equity of 59.65%.
- [By Lisa Levin]
Netshoes (Cayman) Limited (NASDAQ: NETS) shares dipped 43.73 percent to close at $2.87 on Tuesday as the company posted downbeat Q1 results.
Cesca Therapeutics Inc. (NASDAQ: KOOL) shares dropped 29.01 percent to close at $0.80 after reporting Q1 results.
SenesTech, Inc. (NASDAQ: SNES) shares fell 22.2 percent to close at $0.340 after reporting Q1 miss.
Vipshop Holdings Limited (NYSE: VIPS) fell 19.95 percent to close at $12.08 after the company reported weaker-than-expected earnings for its first quarter on Monday.
Image Sensing Systems, Inc. (NASDAQ: ISNS) fell 19.68 percent to close at $3.775 after reporting earnings were down year over year. First quarter earnings came in flat, down from 4 cents per share in the same quarter of last year. Sales came in at $3.01 million.
Boxlight Corporation (NASDAQ: BOXL) dropped 18.47 percent to close at $9.62 on Tuesday after surging 77.44 percent on Monday.
ENDRA Life Sciences Inc. (NASDAQ: NDRA) declined 16.21 percent to close at $2.43. ENDRA Life Sciences is expected to release quarterly earnings today.
ALJ Regional Holdings, Inc. (NASDAQ: ALJJ) shares fell 16.13 percent to close at $1.79.
Switch Inc (NYSE: SWCH) shares dropped 14.93 percent to close at $13.16 following a first-quarter earnings miss.
Restoration Robotics Inc (NASDAQ: HAIR) fell 14.42 percent to close at $3.68 after reporting a first-quarter earnings miss.
iCAD, Inc. (NASDAQ: ICAD) declined 13.01 percent to close at $3.41 following Q1 results.
Intersections Inc. (NASDAQ: INTX) fell 12.44 percent to close at $1.97.
Histogenics Corporation (NASDAQ: HSGX) declined 12.24 percent to close at $2.15.
AZZ Inc. (NYSE: AZZ) fell 12.1 percent to close at $39.60 following Q3 earnings.
Hallador Energy Company (NASDAQ: HNRG) fell 11.1 percent to close at $6.49.
Integrated Media Technology Limited (NASDAQ: IMTE) dropped 10.66 percent to close at $16.93 on Tuesday.
Myomo, Inc. (NYSE: MYO) slipp